Global Blood Therapeutics, Inc. (GBT), is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. More »

Featured News

Recent News

10/04/18GBT Announces New Employment Inducement Grants
10/04/18GBT Announces Upcoming Presentations at National Sickle Cell Disease Association of America (SCDAA) Convention
09/26/18GBT Announces Participation at the 2018 Cantor Global Healthcare Conference
09/07/18GBT Announces Participation at the 2018 Morgan Stanley Global Healthcare Conference

More »

Media Resources

Stay Informed

Sign up to receive email updates about ongoing sickle cell disease clinical studies, awareness and educational information and GBT news at:

Media Contact

Julie Normart